Survival Outcomes in Bladder Cancer: An Ambispective Study of Patients Undergoing Radical Cystectomy

Introduction Radical cystectomy (RC) with pelvic lymph node dissection and urinary diversion is the preferred treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for some high-risk non-muscle invasive bladder cancer (NMIBC), in patients fit for major surgery. Primary objective The primary objective of this study is to estimate the overall survival (OS) of patients with MIBC who have undergone RC. Secondary objective The secondary objectives are to estimate the disease-free survival (DFS) of patients with MIBC following RC and to determine factors that influence OS and DFS in this population. Methodology This was an ambispective study of patients who underwent RC for carcinoma of the urinary bladder between 1st January 2010 and 30th April 2022. Clinicopathological data were obtained from the patients' clinical records. Results The study included a total of 106 patients, with a mean age of 59.35 years. Of these, 55.88% had received neoadjuvant chemotherapy (NACT), and 13 patients (11.7%) underwent salvage cystectomy. Only five patients received intravesical chemotherapy instillation following transurethral resection of bladder tumor (TURBT). RC was performed via laparotomy in 82 patients, while 24 patients underwent a laparoscopic approach. The mean hospital stay was five days. Ninety-eight patients had Clavien-Dindo grade II morbidity. There were no intra-hospital or 30-day mortalities. The histopathologic report showed that 21 patients had achieved pathological complete response (PCR). A total of 96 patients were kept on follow-up, of whom 32 patients had recurrence. Median DFS was 145 months, and median OS was 118 months. PCR was found to be significantly associated with improved DFS. Smoking was found to be a significant predictor of OS on multivariate analysis. Conclusions Although NACT did not reach statistical significance as an independent predictor of survival, it contributed to the achievement of PCR, which was predictive of DFS and OS. Hence, NACT should be pursued wherever feasible. Further, this study shows the importance of smoking cessation, as current or recent smoking was found to have a negative impact on survival among patients with bladder cancer.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-06-28
DOI
https://doi.org/10.7759/cureus.86938
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival Outcomes in Bladder Cancer: An Ambispective Study of Patients Undergoing Radical Cystectomy

Siva Ranjith, Madhu Muralee, John Joseph, K. M. Jagathnath Krishna et al.
Cureus
Bladder and Urothelial Cancer Treatments
article

Survival Outcomes in Bladder Cancer: An Ambispective Study of Patients Undergoing Radical Cystectomy

Siva Ranjith, Madhu Muralee, John Joseph, K. M. Jagathnath Krishna, Paul Augustine, Neelima Radhakrishnan, K Chandramohan, Akhil Thomas Jacob
article en

Abstract

Introduction Radical cystectomy (RC) with pelvic lymph node dissection and urinary diversion is the preferred treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for some high-risk non-muscle invasive bladder cancer (NMIBC), in patients fit for major surgery. Primary objective The primary objective of this study is to estimate the overall survival (OS) of patients with MIBC who have undergone RC. Secondary objective The secondary objectives are to estimate the disease-free survival (DFS) of patients with MIBC following RC and to determine factors that influence OS and DFS in this population. Methodology This was an ambispective study of patients who underwent RC for carcinoma of the urinary bladder between 1st January 2010 and 30th April 2022. Clinicopathological data were obtained from the patients' clinical records. Results The study included a total of 106 patients, with a mean age of 59.35 years. Of these, 55.88% had received neoadjuvant chemotherapy (NACT), and 13 patients (11.7%) underwent salvage cystectomy. Only five patients received intravesical chemotherapy instillation following transurethral resection of bladder tumor (TURBT). RC was performed via laparotomy in 82 patients, while 24 patients underwent a laparoscopic approach. The mean hospital stay was five days. Ninety-eight patients had Clavien-Dindo grade II morbidity. There were no intra-hospital or 30-day mortalities. The histopathologic report showed that 21 patients had achieved pathological complete response (PCR). A total of 96 patients were kept on follow-up, of whom 32 patients had recurrence. Median DFS was 145 months, and median OS was 118 months. PCR was found to be significantly associated with improved DFS. Smoking was found to be a significant predictor of OS on multivariate analysis. Conclusions Although NACT did not reach statistical significance as an independent predictor of survival, it contributed to the achievement of PCR, which was predictive of DFS and OS. Hence, NACT should be pursued wherever feasible. Further, this study shows the importance of smoking cessation, as current or recent smoking was found to have a negative impact on survival among patients with bladder cancer.

CureusVol. 17(6)
Regional Cancer Center, Thiruvananthapuram (IN), Occupational Cancer Research Centre (CA), Institute of Medical Sciences (IN)
Openalex Percentile: Top 74%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.